Description186Re-Rhenium Etidronate (commonly referred to as 186Re-HEDP, hydroxyethylidene diphosphonate, or 186Re-Etidronate) is a radiopharmaceutical developed by Mallinckrodt for palliating bone pain caused by metastatic bone cancer. This innovative formulation was initially approved and launched in Switzerland and Greece. However, despite its potential, the New Drug Application (NDA) submitted to the… Continue Reading…
Description 177Lu-Oxodotreotide (also known as 177Lu-Lutathera®, 177Lu-DOTATATE, and Lutetium-177 dotatate) is a somatostatin analogue developed for the treatment of neuroendocrine tumors (NETs). It was the first 177Lu-labeled molecule to receive marketing authorization. The drug was originally developed by Biosynthema, which was acquired by Advanced Accelerator Applications (AAA) in 2010. The… Continue Reading…
Manufacturer Chengdu Huasun Technology Group (CIRC)131I-Metuximab, marketed under the brand name Licartin, is a radiolabeled murine antibody initially developed by the Fourth Military Medical University. It has been commercialized by Chengdu Huasun Technology Group (previously Chengdu Taihe Health Technology and formerly known as Chengdu Huasun) in collaboration with the China… Continue Reading…
Description 131I-Lipiodol, also known as 131I-Ethiodized Oil or 131I-IOM-40, is a generic therapeutic agent that was first authorized and made available in 1995 by CISbio/IBA Molecular under the brand name Lipiocis®. Lipiodol itself is a mixture of iodinated ethyl esters derived from the fatty acids of poppy seed oil. Originally… Continue Reading…
Description 131I-Iobenguane (commonly referred to as 131I-Metaiodobenzylguanidine or 131I-MIBG) is a radiopharmaceutical used both diagnostically and therapeutically for primary and metastatic pheochromocytomas and paragangliomas. This compound specifically targets adrenergic tissues, making it effective in localizing these neuroendocrine tumors. Azedra™ (formerly known as MIP-120T or Ultratrace MIBG), developed by Progenics (previously… Continue Reading…
Description 131I-Human Serum Albumin (131I-HSA) is a radiopharmaceutical agent utilized in medical diagnostics, primarily for human fluid analysis and imaging applications. It plays a crucial role in determining total blood and plasma volumes for blood analysis and is also employed in the localization of cerebral neoplasms during imaging procedures. Clinical… Continue Reading…